STOCK TITAN

Monte Rosa Therapeutics: Vestal Point reports 8.4%

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Monte Rosa Therapeutics (GLUE) ownership amendment reports that Vestal Point Capital, LP and Ryan Wilder each beneficially own the same 7,130,000 common shares, or 8.4%. The shares are directly held by the Vestal Point Fund and Account, and both reporting persons report shared voting and dispositive power over them. Wilder is Vestal Point Capital’s Chief Investment Officer and Managing Partner.

The reported percentage is based on 85,313,401 shares outstanding as of July 31, 2026. The Fund and Account have the right to receive, or direct receipt of, dividends and sale proceeds from the shares.

Beneficially owned shares 7,130,000 shares The same shares are reported by Vestal Point Capital, LP and Ryan Wilder.
Ownership percentage 8.4% Reported by each reporting person.
Shared voting power 7,130,000 shares Reported by each reporting person.
Shared dispositive power 7,130,000 shares Reported by each reporting person.
Shares outstanding 85,313,401 shares As of July 31, 2026; basis for the reported ownership percentage.
beneficially owned regulatory
"Aggregate amount beneficially owned by each reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared voting power over the reported shares"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power over the reported shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GLUE shares do Vestal Point Capital and Ryan Wilder report?

They each report beneficial ownership of the same 7,130,000 shares, equal to 8.4% of the class. The shares are directly held by the Vestal Point Fund and Account, and the reporting persons report shared voting and dispositive power over them.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





61225M102

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Vestal Point Capital, LP
Signature:/s/ Ryan Wilder
Name/Title:By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
Date:11/16/2026
Ryan Wilder
Signature:/s/ Ryan Wilder
Name/Title:Ryan Wilder, Individually
Date:11/16/2026

Keep reading